158 related articles for article (PubMed ID: 21212966)
1. Adjuvant chemotherapy for resected colon cancer: comparison of the prognostic value of tumour and patient related factors.
Roxburgh C; McDonald A; Salmond J; Oien K; Anderson J; McKee R; Horgan P; McMillan D
Int J Colorectal Dis; 2011 Apr; 26(4):483-92. PubMed ID: 21212966
[TBL] [Abstract][Full Text] [Related]
2. The relationship between right-sided tumour location, tumour microenvironment, systemic inflammation, adjuvant therapy and survival in patients undergoing surgery for colon and rectal cancer.
Patel M; McSorley ST; Park JH; Roxburgh CSD; Edwards J; Horgan PG; McMillan DC
Br J Cancer; 2018 Mar; 118(5):705-712. PubMed ID: 29337962
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer.
Roxburgh CS; Salmond JM; Horgan PG; Oien KA; McMillan DC
Ann Surg; 2009 May; 249(5):788-93. PubMed ID: 19387324
[TBL] [Abstract][Full Text] [Related]
4. The relationship between the local and systemic inflammatory responses and survival in patients undergoing curative surgery for colon and rectal cancers.
Roxburgh CS; Salmond JM; Horgan PG; Oien KA; McMillan DC
J Gastrointest Surg; 2009 Nov; 13(11):2011-8; discussion 2018-9. PubMed ID: 19768511
[TBL] [Abstract][Full Text] [Related]
5. Comparison of tumour-based (Petersen Index) and inflammation-based (Glasgow Prognostic Score) scoring systems in patients undergoing curative resection for colon cancer.
Roxburgh CS; Crozier JE; Maxwell F; Foulis AK; Brown J; McKee RF; Anderson JH; Horgan PG; McMillan DC
Br J Cancer; 2009 Mar; 100(5):701-6. PubMed ID: 19209171
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy for resected stage II and III colon cancer: comparison of two widely used prognostic calculators.
Bardia A; Loprinzi C; Grothey A; Nelson G; Alberts S; Menon S; Thome S; Gill S; Sargent D
Semin Oncol; 2010 Feb; 37(1):39-46. PubMed ID: 20172363
[TBL] [Abstract][Full Text] [Related]
7. Preoperative inflammatory response as prognostic factor of patients with colon cancer.
Matsubara D; Arita T; Nakanishi M; Kuriu Y; Murayama Y; Kudou M; Shoda K; Kosuga T; Konishi H; Morimura R; Shiozaki A; Ikoma H; Kubota T; Fujiwara H; Okamoto K; Otsuji E
Langenbecks Arch Surg; 2019 Sep; 404(6):731-741. PubMed ID: 31468113
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of tumour necrosis and host inflammatory responses in colorectal cancer.
Richards CH; Roxburgh CS; Anderson JH; McKee RF; Foulis AK; Horgan PG; McMillan DC
Br J Surg; 2012 Feb; 99(2):287-94. PubMed ID: 22086662
[TBL] [Abstract][Full Text] [Related]
9. The prognostic impact of primary tumour location in patients with stage II and stage III colon cancer receiving adjuvant therapy. A GISCAD analysis from three large randomised trials.
Cascinu S; Poli D; Zaniboni A; Lonardi S; Labianca R; Sobrero A; Rosati G; Di Bartolomeo M; Scartozzi M; Zagonel V; Pella N; Banzi M; Torri V
Eur J Cancer; 2019 Apr; 111():1-7. PubMed ID: 30797014
[TBL] [Abstract][Full Text] [Related]
10. Defining a high-risk subgroup with colon cancer stages I and II for possible adjuvant therapy.
Gertler R; Rosenberg R; Schuster T; Friess H
Eur J Cancer; 2009 Nov; 45(17):2992-9. PubMed ID: 19682890
[TBL] [Abstract][Full Text] [Related]
11. Caspase-3 activity, response to chemotherapy and clinical outcome in patients with colon cancer.
de Oca J; Azuara D; Sanchez-Santos R; Navarro M; Capella G; Moreno V; Sola A; Hotter G; Biondo S; Osorio A; Martí-Ragué J; Rafecas A
Int J Colorectal Dis; 2008 Jan; 23(1):21-7. PubMed ID: 17805550
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial.
Klaver CEL; Wisselink DD; Punt CJA; Snaebjornsson P; Crezee J; Aalbers AGJ; Brandt A; Bremers AJA; Burger JWA; Fabry HFJ; Ferenschild F; Festen S; van Grevenstein WMU; Hemmer PHJ; de Hingh IHJT; Kok NFM; Musters GD; Schoonderwoerd L; Tuynman JB; van de Ven AWH; van Westreenen HL; Wiezer MJ; Zimmerman DDE; van Zweeden AA; Dijkgraaf MGW; Tanis PJ;
Lancet Gastroenterol Hepatol; 2019 Oct; 4(10):761-770. PubMed ID: 31371228
[TBL] [Abstract][Full Text] [Related]
13. LINE-1 Methylation Status Correlates Significantly to Post-Therapeutic Recurrence in Stage III Colon Cancer Patients Receiving FOLFOX-4 Adjuvant Chemotherapy.
Lou YT; Chen CW; Fan YC; Chang WC; Lu CY; Wu IC; Hsu WH; Huang CW; Wang JY
PLoS One; 2014; 10(4):e0123973. PubMed ID: 25919688
[TBL] [Abstract][Full Text] [Related]
14. Clinical impact of elastic laminal invasion in colon cancer: elastic laminal invasion-positive stage II colon cancer is a high-risk equivalent to stage III.
Yokota M; Kojima M; Nomura S; Nishizawa Y; Kobayashi A; Ito M; Ochiai A; Saito N
Dis Colon Rectum; 2014 Jul; 57(7):830-8. PubMed ID: 24901683
[TBL] [Abstract][Full Text] [Related]
15. Fluorouracil plus leucovorin as effective adjuvant chemotherapy in curatively resected stage III colon cancer: results of the trial adjCCA-01.
Porschen R; Bermann A; Löffler T; Haack G; Rettig K; Anger Y; Strohmeyer G;
J Clin Oncol; 2001 Mar; 19(6):1787-94. PubMed ID: 11251010
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy and prognostic factors in stage II colon cancer--Izmir Oncology Group Study.
Kucukzeybek Y; Dirican A; Demir L; Yildirim S; Akyol M; Yildiz Y; Bayoglu IV; Alacacioglu A; Varol U; Salman T; Yildiz I; Can H; Tarhan MO
Asian Pac J Cancer Prev; 2015; 16(6):2413-8. PubMed ID: 25824774
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors of colorectal cancer. Results of multivariate analysis of curative resection cases with or without adjuvant chemotherapy.
Takahashi T; Kato T; Kodaira S; Koyama Y; Sakabe T; Tominaga T; Hamano K; Yasutomi M; Ogawa N
Am J Clin Oncol; 1996 Aug; 19(4):408-15. PubMed ID: 8677916
[TBL] [Abstract][Full Text] [Related]
18. The relationship between tumour site, clinicopathological characteristics and cancer-specific survival in patients undergoing surgery for colorectal cancer.
Powell AG; Wallace R; McKee RF; Anderson JH; Going JJ; Edwards J; Horgan PG
Colorectal Dis; 2012 Dec; 14(12):1493-9. PubMed ID: 22507826
[TBL] [Abstract][Full Text] [Related]
19. Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis.
Ejaz A; Casadaban L; Maker AV
J Surg Res; 2017 Jul; 215():12-20. PubMed ID: 28688636
[TBL] [Abstract][Full Text] [Related]
20. [Predictive and Prognostic significance of high-sensitivity modified Glasgow Prognostic Score (HS-mGPS) in advanced gastric cancer patients treated with neoadjuvant chemotherapy].
Cui Y; Li J; Cao YH; Liu MY; Shi ZX; Gao TH
Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):195-200. PubMed ID: 28316218
[No Abstract] [Full Text] [Related]
[Next] [New Search]
